NexImmune NEXI Stock
NexImmune Price Chart
NexImmune NEXI Financial and Trading Overview
| NexImmune stock price | 3.61 USD |
| Previous Close | 0.32 USD |
| Open | 0.31 USD |
| Bid | 0 USD x 1800 |
| Ask | 0 USD x 900 |
| Day's Range | 0.29 - 0.33 USD |
| 52 Week Range | 0.2 - 2.29 USD |
| Volume | 274.1K USD |
| Avg. Volume | 253.59K USD |
| Market Cap | 8.51M USD |
| Beta (5Y Monthly) | 2.309505 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -42.05 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 2 USD |
NEXI Valuation Measures
| Enterprise Value | -13081950 USD |
| Trailing P/E | N/A |
| Forward P/E | -2.0387502 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 0.36084074 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | 0.23 |
Trading Information
NexImmune Stock Price History
| Beta (5Y Monthly) | 2.309505 |
| 52-Week Change | -82.56% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 2.29 USD |
| 52 Week Low | 0.2 USD |
| 50-Day Moving Average | 0.35 USD |
| 200-Day Moving Average | 0.48 USD |
NEXI Share Statistics
| Avg. Volume (3 month) | 253.59K USD |
| Avg. Daily Volume (10-Days) | 139.71K USD |
| Shares Outstanding | 26.08M |
| Float | 17.32M |
| Short Ratio | 0.71 |
| % Held by Insiders | 28.23% |
| % Held by Institutions | 24.20% |
| Shares Short | 317.18K |
| Short % of Float | 1.39% |
| Short % of Shares Outstanding | 1.22% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -66.36% |
| Return on Equity (ttm) | -121.41% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | -56823176 USD |
| Net Income Avi to Common (ttm) | -57048272 USD |
| Diluted EPS (ttm) | -2.36 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 22.32M USD |
| Total Cash Per Share (mrq) | 0.86 USD |
| Total Debt (mrq) | 888.16K USD |
| Total Debt/Equity (mrq) | 3.77 USD |
| Current Ratio (mrq) | 3.744 |
| Book Value Per Share (mrq) | 0.904 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -46999860 USD |
| Levered Free Cash Flow (ttm) | -27520928 USD |
Profile of NexImmune
| Country | United States |
| State | MD |
| City | Gaithersburg |
| Address | 9119 Gaither Road |
| ZIP | 20877 |
| Phone | 301 825 9810 |
| Website | https://www.neximmune.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 50 |
NexImmune, Inc., a clinical-stage biotechnology company, engages in developing therapies with curative potential for patients with cancer and other life-threatening immune-mediated diseases. It develops approaches to T cell immunotherapies based on its proprietary Artificial Immune Modulation, a nanoparticle technology platform. The company's product candidates include NEXI-001, an allogeneic cell therapy, which is in Phase I/II clinical trials for the treatment of patients with acute myeloid leukemia; NEXI-002, an autologous cell therapy that is in Phase I/II clinical trials for the treatment of patients with relapsed and/or refractory in multiple myeloma; and NEXI-003, a candidate targeted against HPV-associated malignancies, which is in preclinical stage. The company was incorporated in 2011 and is headquartered in Gaithersburg, Maryland.
Q&A For NexImmune Stock
What is a current NEXI stock price?
NexImmune NEXI stock price today per share is 3.61 USD.
How to purchase NexImmune stock?
You can buy NEXI shares on the NasdaqCM exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for NexImmune?
The stock symbol or ticker of NexImmune is NEXI.
Which industry does the NexImmune company belong to?
The NexImmune industry is Biotechnology.
How many shares does NexImmune have in circulation?
The max supply of NexImmune shares is 1.3M.
What is NexImmune Price to Earnings Ratio (PE Ratio)?
NexImmune PE Ratio is now.
What was NexImmune earnings per share over the trailing 12 months (TTM)?
NexImmune EPS is -42.05 USD over the trailing 12 months.
Which sector does the NexImmune company belong to?
The NexImmune sector is Healthcare.
NexImmune NEXI included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| NASDAQ Composite IXIC | 16175.09 USD — |
-1.62
|
3.94B USD — | 16125.33 USD — | 16341.46 USD — | — - | 3.94B USD — |
| NASDAQ Global Market Composite NQGM | 2160.36 USD — |
-2.45
|
— — | 2147.48 USD — | 2200.33 USD — | — - | — — |
| NASDAQ HealthCare IXHC | 958.68 USD — |
-2.07
|
— — | 954.08 USD — | 972.42 USD — | — - | — — |
- {{ link.label }} {{link}}